Kim Seong-hyun, CEO of Blue Ant (right), and Kim Dae-jin, CEO of Song-Ari IT, are posing for a commemorative photo after signing a business agreement.
[Asia Economy Reporter Lee Gwan-joo] BlueAnt, which operates the non-face-to-face medical consultation and medicine delivery platform 'Ollacare,' announced on the 23rd that it has signed a business agreement for chronic disease business cooperation with Songari IT, which operates an integrated health management service app for diabetes and hypertension patients.
Through this agreement, Ollacare plans to actively expand its services for chronic disease patients. Songari IT operates the 'Songari Diabetes App' for diabetes chronic disease patients, which replaces the cumbersome diabetes notebook and allows easy management of blood sugar, blood pressure, meal intake, and exercise, as well as the 'Songari Hypertension App' for hypertension chronic disease patients who require consistent management of blood pressure, weight, and diet. Patients input their health information through the app, and doctors can immediately understand the patients' health status by linking it to the web.
Kim Sung-hyun, CEO of BlueAnt, said, "The increase in lifestyle-related chronic diseases may not be due to the limitations of medical standards or drug treatment efficacy, but rather the inability to maintain continuous treatment and management due to busy daily lives. Non-face-to-face medical consultation can be a good alternative," adding, "Through this agreement, Ollacare will grow into a 'customized healthcare platform' that can improve daily lifestyle habits and provide differentiated services."
Kim Dae-jin, CEO of Songari IT, stated, "Songari IT, which aims to be a medical communication platform based on accurate data, is also in the process of expanding its scope to an integrated health management platform that can manage various chronic diseases, and we believe we can create synergy with Ollacare."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
